相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A time delay model of tumour-immune system interactions: Global dynamics, parameter estimation, sensitivity analysis
F. A. Rihan et al.
APPLIED MATHEMATICS AND COMPUTATION (2014)
Modelling Lymphoma Therapy and Outcome
Katja Roesch et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2014)
High-Dose IL2 in Metastatic Melanoma: Better Survival in Patients Immunized with Antigens from Autologous Tumor Cell Lines
Robert O. Dillman et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2014)
MATHEMATICAL MODELING ON HELPER T CELLS IN A TUMOR IMMUNE SYSTEM
Yueping Dong et al.
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B (2014)
Natural Killer or T-lymphocyte Cells: Which is the Best Immune Therapeutic Agent for Cancer? An Optimal Control Approach
Sanaz Nazari et al.
INTERNATIONAL JOURNAL OF CONTROL AUTOMATION AND SYSTEMS (2014)
Mathematical Modeling of Interleukin-27 Induction of Anti-Tumor T Cells Response
Kang-Ling Liao et al.
PLOS ONE (2014)
Spreaders and Sponges Define Metastasis in Lung Cancer: A Markov Chain Monte Carlo Mathematical Model
Paul K. Newton et al.
CANCER RESEARCH (2013)
B CELL CHRONIC LYMPHOCYTIC LEUKEMIA - A MODEL WITH IMMUNE RESPONSE
Seema Nanda et al.
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B (2013)
MATHEMATICAL MODELING OF REGULATORY T CELL EFFECTS ON RENAL CELL CARCINOMA TREATMENT
Lisette de Pillis et al.
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B (2013)
Modeling cancer immunotherapy: Assessing the effects of lymphocytes on cancer cell growth and motility
R. A. Ramos et al.
PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS (2013)
Recent developments on immunotherapy for brain cancer
Derek A. Wainwright et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Translating Mathematical Modeling of Tumor Growth Patterns into Novel Therapeutic Approaches for Breast Cancer
Elizabeth Comen et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2012)
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study
Freddie Bray et al.
LANCET ONCOLOGY (2012)
Laser interstitial thermotherapy of small breast fibroadenomas: Numerical simulations
Mohamad Feras Marqa et al.
LASERS IN SURGERY AND MEDICINE (2012)
Mathematical Modeling in Immunotherapy of Cancer: Personalizing Clinical Trials
Zvia Agur et al.
MOLECULAR THERAPY (2012)
Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia
Dana Paquin et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2011)
Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models
Raluca Eftimie et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integration of panitumumab into the treatment of colorectal cancer
Cristina Gravalos et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Mathematical Model Creation for Cancer Chemo-Immunotherapy
Lisette de Pillis et al.
Computational and Mathematical Methods in Medicine (2009)
The Emerging Low-dose Therapy for Advanced Cancers
Jahangir Satti
Dose-Response (2009)
Modeling Combined Radiopharmaceutical Therapy: A Linear Optimization Framework
Ian M. Besse et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2009)
New Computational Tools for Modeling Chronic Myelogenous Leukemia
M. M. Peet et al.
MATHEMATICAL MODELLING OF NATURAL PHENOMENA (2009)
A PDE model for imatinib-treated chronic myelogenous leukemia
Peter S. Kim et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2008)
Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model
Boris Gorelik et al.
CANCER RESEARCH (2008)
Optimal control of mixed immunotherapy and chemotherapy of tumors
L. G. De Pillis et al.
JOURNAL OF BIOLOGICAL SYSTEMS (2008)
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer
Tiffany A. Traina et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Metamodeling tumor-immune system interaction, tumor evasion and immunotherapy
Alberto d'Onofrio
MATHEMATICAL AND COMPUTER MODELLING (2008)
Dynamics and potential impact of the immune response to chronic myelogenous leukemia
Peter S. Kim et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Modeling imatinib-treated chronic myelogenous leukemia: Reducing the complexity of agent-based models
Peter S. Kim et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2008)
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics
Natalie Kronik et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
L. G. de Pillis et al.
MATHEMATICAL BIOSCIENCES (2007)
Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells
Olivier Preynat-Seauve et al.
MELANOMA RESEARCH (2007)
Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells
Tae-Hyung Lee et al.
BIOTECHNOLOGY LETTERS (2007)
Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications
Ingo Roeder et al.
NATURE MEDICINE (2006)
Cancer immunotherapy by interleukin-21: Potential treatment strategies evaluated in a mathematical model
Antonio Cappuccio et al.
CANCER RESEARCH (2006)
Looking for new paradigms towards a biological-mathematical theory of complex multicellular systems
Nicola Bellomo et al.
MATHEMATICAL MODELS & METHODS IN APPLIED SCIENCES (2006)
A cellular automata model of tumor-immune system interactions
DG Mallet et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
LG de Pillis et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
Optimal control in a model of dendritic cell transfection cancer immunotherapy
F Castiglione et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2006)
A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
A d'Onofrio
PHYSICA D-NONLINEAR PHENOMENA (2005)
Dynamics of chronic myeloid leukaemia
F Michor et al.
NATURE (2005)
CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2
PA Antony et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Dynamic response of cancer under the influence of immunological activity and therapy
HP de Vladar et al.
JOURNAL OF THEORETICAL BIOLOGY (2004)
Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction
B Ludewig et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas:: results of the NHL-B1 trial of the DSHNHL
M Pfreundschuh et al.
BLOOD (2004)
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:: results of the NHL-B2 trial of the DSHNHL
M Pfreundschuh et al.
BLOOD (2004)
Mathematical topics on the modelling complex multicellular systems and tumor immune cells competition
N Bellomo et al.
MATHEMATICAL MODELS & METHODS IN APPLIED SCIENCES (2004)
Development of effective immunotherapy for the treatment of patients with cancer
SA Rosenberg
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
The dynamics of an optimally controlled tumor model: A case study
LG De Pillis et al.
MATHEMATICAL AND COMPUTER MODELLING (2003)
The modelling of the immune competition by generalized kinetic (Boltzmann) models: Review and research perspectives
N Bellomo et al.
MATHEMATICAL AND COMPUTER MODELLING (2003)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes
T Takayanagi et al.
MICROBIOLOGY AND IMMUNOLOGY (2001)
Modelling and mathematical problems related to tumor evolution and its interaction with the immune system
N Bellomo et al.
MATHEMATICAL AND COMPUTER MODELLING (2000)
分享论文
